• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四个中心下尿路症状与勃起功能障碍之间的关联:UrEpik研究

The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study.

作者信息

Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade R, Kiemeney L, Lee C

机构信息

Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

出版信息

BJU Int. 2003 Nov;92(7):719-25. doi: 10.1046/j.1464-410x.2003.04459.x.

DOI:10.1046/j.1464-410x.2003.04459.x
PMID:14616454
Abstract

OBJECTIVE

To report a large-scale multinational investigation of lower urinary tract symptoms (LUTS) and sexual function, designed to investigate the independent association between them, as recent small-scale epidemiological studies suggest an association between benign prostatic hyperplasia and sexual dysfunction; both conditions are strongly associated with age and no study has been able to exclude age as a confounding factor in this relationship.

SUBJECTS AND METHODS

Culturally and linguistically validated versions of standard questionnaires were used to estimate the prevalence of LUTS (using the International Prostate Symptom Score, IPSS) and erectile dysfunction (ED) score (using O'Leary's Sexual Function Inventory) in regions of the UK (Birmingham), the Netherlands (Boxmeer), France (Auxerre) and Korea (Seoul). In each centre, stratified random samples were selected from population registers to provide representative samples of the population of men aged 40-79 years (and their partners) in each community. Direct interviews were held in Seoul and postal questionnaires used in the three European centres. The samples were selected randomly, providing representative samples in each community.

RESULTS

In all, 4800 men and 3674 women responded; the response rates among men were 77% in Boxmeer, 21% in Auxerre, 42% in Birmingham and 65% in Seoul. The overall prevalence of ED for men aged 40-79, estimated as an ED score of 0-4, was 21.1%. There was evidence of a linear increase with age (P < 0.001) and the pattern was very similar in the four centres. From the weighted logistic model, there was evidence of an association between sexual dysfunction, other self-reported diseases and lifestyle. From the ED score, after adjusting for age and country, men with diabetes were more likely to score of 0-4 (odds ratio 1.57, 95% confidence interval 1.09-2.25), as were those with high blood pressure (1.38, 1.09-1.75) and with an IPSS of 8-35 (1.39, 1.10-1.74). For lifestyle, smokers were more likely to score 0-4 (1.54, 1.23-1.92), while physical activity during leisure time was slightly associated with a reduction in the chance of scoring 0-4 (0.87, 0.77-0.99). The analysis gave the same results when repeated using self-reported ED instead of the dichotomised score.

CONCLUSIONS

ED is clearly age-related and a problem for a large proportion of men in the community. It can have a profound impact on the quality of life of the man and on his partner. Were all men with this problem to seek medical help there would be a large burden on healthcare systems. There are cultural and age effects on the assessment of this problem.

摘要

目的

报告一项关于下尿路症状(LUTS)与性功能的大规模跨国调查,旨在研究它们之间的独立关联。因为近期小规模流行病学研究表明良性前列腺增生与性功能障碍之间存在关联;这两种情况都与年龄密切相关,且尚无研究能够排除年龄作为这种关系中的混杂因素。

对象与方法

使用经过文化和语言验证的标准问卷版本,在英国伯明翰、荷兰博克斯梅尔、法国欧塞尔和韩国首尔等地,评估LUTS的患病率(采用国际前列腺症状评分,即IPSS)和勃起功能障碍(ED)评分(采用奥利里性功能量表)。在每个中心,从人口登记册中选取分层随机样本,以提供各社区40 - 79岁男性(及其伴侣)人群的代表性样本。在首尔进行直接访谈,在三个欧洲中心使用邮寄问卷。样本随机选取,以在每个社区提供代表性样本。

结果

共有4800名男性和3674名女性做出回应;男性的回应率在博克斯梅尔为77%,在欧塞尔为21%,在伯明翰为42%,在首尔为65%。40 - 79岁男性中,以ED评分为0 - 4来估计,ED的总体患病率为21.1%。有证据表明其随年龄呈线性增加(P < 0.001),且在四个中心的模式非常相似。从加权逻辑模型来看,有证据表明性功能障碍、其他自我报告的疾病和生活方式之间存在关联。从ED评分来看,在调整年龄和国家因素后,患有糖尿病的男性更有可能得0 - 4分(优势比1.57,95%置信区间1.09 - 2.25),患有高血压的男性也是如此(1.38,1.09 - 1.75),IPSS为8 - 35的男性同样如此(1.39,1.10 - 1.74)。对于生活方式,吸烟者更有可能得0 - 4分(1.54,1.23 - 1.92),而休闲时间进行体育活动与得0 - 4分的几率略有降低相关(0.87,0.77 - 0.99)。当使用自我报告的ED而非二分法评分重复分析时,得到了相同的结果。

结论

ED显然与年龄相关,是社区中很大一部分男性面临的问题。它会对男性及其伴侣的生活质量产生深远影响。如果所有有此问题的男性都寻求医疗帮助,将给医疗系统带来巨大负担。在对这个问题的评估上存在文化和年龄方面的影响。

相似文献

1
The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study.四个中心下尿路症状与勃起功能障碍之间的关联:UrEpik研究
BJU Int. 2003 Nov;92(7):719-25. doi: 10.1046/j.1464-410x.2003.04459.x.
2
The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study.四个中心男性和女性下尿路症状的患病率。UrEpik研究。
BJU Int. 2003 Sep;92(4):409-14. doi: 10.1046/j.1464-410x.2003.04369.x.
3
The relationship between lower urinary tract symptoms and health status: the UREPIK study.下尿路症状与健康状况之间的关系:UREPIK研究。
BJU Int. 2003 Oct;92(6):575-80. doi: 10.1046/j.1464-410x.2003.04448.x.
4
The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies.下尿路症状及合并症对生活质量的影响:BACH和UREPIK研究
BJU Int. 2007 Feb;99(2):347-54. doi: 10.1111/j.1464-410X.2007.06609.x.
5
The prevalence of male urinary incontinence in four centres: the UREPIK study.四个中心男性尿失禁的患病率:UREPIK研究
BJU Int. 2003 Dec;92(9):943-7. doi: 10.1111/j.1464-410x.2003.04526.x.
6
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).下尿路症状与男性性功能障碍:老年男性多国调查(MSAM-7)
Eur Urol. 2003 Dec;44(6):637-49. doi: 10.1016/j.eururo.2003.08.015.
7
[Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].[下尿路症状与男性性功能障碍:衰老男性的多国调查(MSAM-7)]
Prog Urol. 2004 Jun;14(3):332-44.
8
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.良性前列腺增生(BPH)与前列腺炎:临床诊断为BPH的男性中射精疼痛的患病率
BJU Int. 2005 Mar;95(4):571-4. doi: 10.1111/j.1464-410X.2005.05341.x.
9
[Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].[有症状的良性前列腺增生男性的性功能评估]
Zhonghua Nan Ke Xue. 2005 Jul;11(7):505-7.
10
Danish Prostatic Symptom Score is not associated with lower urinary tract symptom severity.
Acta Chir Belg. 2009 Nov-Dec;109(6):751-5. doi: 10.1080/00015458.2009.11680529.

引用本文的文献

1
Lower Urinary Tract Symptoms Correlate with Erectile Dysfunction and Premature Ejaculation but Not with Men's Sexual Activity: Results from a Large Population-Representative Study.下尿路症状与勃起功能障碍和早泄相关,但与男性性活动无关:一项大型代表性人群研究的结果
Healthcare (Basel). 2024 Jul 15;12(14):1408. doi: 10.3390/healthcare12141408.
2
The association of various physical activities with erectile dysfunction: NHANES 2001-2004.2001 - 2004年美国国家健康与营养检查调查(NHANES):各类体育活动与勃起功能障碍的关联
Sex Med. 2023 Jul 25;11(3):qfad036. doi: 10.1093/sexmed/qfad036. eCollection 2023 Jun.
3
Reaching a Tipping Point: A Qualitative Exploration of Quality of Life and Treatment Decision-Making in People Living With Benign Prostatic Hyperplasia.
达到临界点:良性前列腺增生患者生活质量和治疗决策的定性探讨。
Qual Health Res. 2022 Nov;32(13):1979-1992. doi: 10.1177/10497323221129262. Epub 2022 Sep 26.
4
Green & Sensitive pH-dependent Spectrofluorimetric Assay of Tamsulosin Hydrochloride and Tadalafil in their New Combined Formulation for Benign Prostatic Hyperplasia: Application to Spiked Human Plasma.盐酸坦索罗辛和他达拉非新复方制剂用于良性前列腺增生的绿敏型 pH 值依赖光谱荧光分析法测定:加标人血浆中的应用。
J Fluoresc. 2022 Jul;32(4):1581-1590. doi: 10.1007/s10895-022-02938-x. Epub 2022 May 16.
5
A narrative review of the management of benign prostatic hyperplasia in patients undergoing penile prosthesis surgery.接受阴茎假体手术患者良性前列腺增生管理的叙述性综述
Transl Androl Urol. 2021 Jun;10(6):2695-2704. doi: 10.21037/tau-20-1225.
6
Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction.治疗良性前列腺增生和勃起功能障碍患者的固定剂量组合他达拉非(5 毫克)和坦索罗辛(0.4 毫克)的治疗持久性和早期停药的原因。
Investig Clin Urol. 2020 Jan;61(1):81-87. doi: 10.4111/icu.2020.61.1.81. Epub 2019 Nov 26.
7
The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue.第一代磷酸二酯酶 5 抑制剂及其药代动力学问题。
Andrology. 2019 Nov;7(6):804-817. doi: 10.1111/andr.12683. Epub 2019 Jul 26.
8
Obesity and Sexual Functioning.肥胖与性功能
Curr Obes Rep. 2018 Dec;7(4):301-307. doi: 10.1007/s13679-018-0319-6.
9
Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries.服用磷酸二酯酶5抑制剂的勃起功能障碍男性的性行为习惯:一项在7个国家开展的调查
Int J Clin Pract. 2018 Apr;72(4):e13074. doi: 10.1111/ijcp.13074. Epub 2018 Feb 20.
10
The relationship between histological prostatitis and lower urinary tract symptoms and sexual function.组织学前列腺炎与下尿路症状及性功能之间的关系。
Int Braz J Urol. 2016 May-Jun;42(3):540-5. doi: 10.1590/S1677-5538.IBJU.2015.0254.